Literature DB >> 5114920

Studies on poly (adenosine diphosphate-ribose). X. Properties of a partially purified poly (adenosine diphosphate-ribose) polymerase.

M Yamada, M Miwa, T Sugimura.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5114920     DOI: 10.1016/0003-9861(71)90164-0

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


× No keyword cloud information.
  6 in total

Review 1.  PARP inhibition: PARP1 and beyond.

Authors:  Michèle Rouleau; Anand Patel; Michael J Hendzel; Scott H Kaufmann; Guy G Poirier
Journal:  Nat Rev Cancer       Date:  2010-03-04       Impact factor: 60.716

2.  Poly(adenosine diphosphate ribose) polymerase in Physarum polycephalum.

Authors:  M D Brightwell; C E Leech; M K O'Farrell; W J Whish; S Shall
Journal:  Biochem J       Date:  1975-04       Impact factor: 3.857

3.  ADP-ribosyltransferase in Plasmodium (malaria parasites).

Authors:  E E Okolie; N I Onyezili
Journal:  Biochem J       Date:  1983-03-01       Impact factor: 3.857

4.  E7449: A dual inhibitor of PARP1/2 and tankyrase1/2 inhibits growth of DNA repair deficient tumors and antagonizes Wnt signaling.

Authors:  Sharon McGonigle; Zhihong Chen; Jiayi Wu; Paul Chang; Donna Kolber-Simonds; Karen Ackermann; Natalie C Twine; Jue-Lon Shie; Jingzang Tao Miu; Kuan-Chun Huang; George A Moniz; Kenichi Nomoto
Journal:  Oncotarget       Date:  2015-12-01

Review 5.  PARP Power: A Structural Perspective on PARP1, PARP2, and PARP3 in DNA Damage Repair and Nucleosome Remodelling.

Authors:  Lotte van Beek; Éilís McClay; Saleha Patel; Marianne Schimpl; Laura Spagnolo; Taiana Maia de Oliveira
Journal:  Int J Mol Sci       Date:  2021-05-12       Impact factor: 5.923

6.  An evaluation in vitro of PARP-1 inhibitors, rucaparib and olaparib, as radiosensitisers for the treatment of neuroblastoma.

Authors:  Donna L Nile; Colin Rae; Iain J Hyndman; Mark N Gaze; Robert J Mairs
Journal:  BMC Cancer       Date:  2016-08-11       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.